CD13 as a potential membrane marker in PSMA-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging

被引：0
|
作者：
Tang, W. [1 ]
Zhou, M. [2 ]
Lu, C. [2 ]
Qi, L. [1 ]
Zhang, Y. [3 ]
Tang, Y. [2 ]
Gao, X. [4 ]
Hu, S. [2 ]
Cai, Y. [1 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Urol, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Nucl Med, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Oncol, Changsha, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Pathol, Changsha, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
中国国家自然科学基金; 中国博士后科学基金;
关键词：
D O I：
10.1016/j.annonc.2024.10.378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
359P
引用
收藏
页数：2
相关论文
共 32 条
  • [1] CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging
    Tang, Wei
    Zhou, Ming
    Lu, Chenxi
    Qi, Lin
    Zhang, Ye
    Tang, Yongxiang
    Gao, Xiaomei
    Hu, Shuo
    Cai, Yi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [2] CD13 as a Potential Membrane Marker in PSMA-Negative Prostate Cancer: A Complementary or Superior Alternative to PSMA
    Tang, Y.
    Xiao, L.
    Yang, J.
    Hou, J.
    Hong, J.
    Rominger, A.
    Shi, K.
    Hu, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S195 - S195
  • [3] Preclinical evaluation and first-in-human study of [18F]AlF-FAP-NUR for PET imaging cancer-associated fibroblasts
    Liu, Shaoyu
    Zhang, Ziqi
    Zhong, Jiawei
    Zhong, Huizhen
    Fu, Yimin
    Liu, Lifang
    Ye, Xiaoting
    Wang, Xinlu
    EJNMMI RESEARCH, 2024, 14 (01):
  • [4] First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
    Ruiyue Zhao
    Miao Ke
    Jie Lv
    Shaoyu Liu
    Yuheng Liu
    Jing Zhang
    Lifu Xu
    Di Gu
    Mingzhao Li
    Chao Cai
    Yongda Liu
    Guohua Zeng
    David Alexoff
    Karl Ploessl
    Lin Zhu
    Hank F. Kung
    Xinlu Wang
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1753 - 1762
  • [5] First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
    Zhao, Ruiyue
    Ke, Miao
    Lv, Jie
    Liu, Shaoyu
    Liu, Yuheng
    Zhang, Jing
    Xu, Lifu
    Gu, Di
    Li, Mingzhao
    Cai, Chao
    Liu, Yongda
    Zeng, Guohua
    Alexoff, David
    Ploessl, Karl
    Zhu, Lin
    Kung, Hank F.
    Wang, Xinlu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (06) : 1753 - 1762
  • [6] First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: Dosimetry and initial evaluation in prostate cancer patients
    Zhao, Ruiyue
    Ke, Miao
    Ploessl, Karl
    Alexoff, David
    Zhu, Lin
    Kung, Hank
    Wang, Xinlu
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [7] Evaluation of a new 18F-labeled NGR peptide for PET imaging of CD13 receptor expression in lung cancer
    Zhang, Jun
    Wu, Hubing
    Conti, Peter
    Chen, Kai
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [8] Preclinical study and first-in-human imaging of [18F]FAP-2286, and comparison with 2-[18F]FDG PET/CT in various cancer patients
    Liu, Lifang
    Zhong, Jiawei
    Zhang, Ziqi
    Ye, Xiaoting
    Wang, Xinlu
    Liu, Shaoyu
    Zhang, Zhanwen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (07) : 2012 - 2022
  • [9] First-in-human phase 1 PET study of CTT1057, a novel 18F-labeled imaging agent targeting prostate specific membrane antigen (PSMA) in prostate cancer.
    Aggarwal, Rahul Raj
    Behr, Spencer
    Seo, Youngho
    Gao, Kenneth
    Rahanfar, Vahid
    Slater, Jim
    Blecha, Joseph
    Langton-Webster, Beatrice
    Berkman, Clifford
    Vanbrocklin, Henry
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study
    Aras, Omer
    Demirdag, Cetin
    Kommidi, Harikrishna
    Guo, Hua
    Pavlova, Ina
    Aygun, Aslan
    Karayel, Emre
    Pehlivanoglu, Huseyin
    Yeyin, Nami
    Kyprianou, Natasha
    Chen, Nandi
    Harmsen, Stefan
    Sonmezoglu, Kerim
    Lundon, Dara J.
    Oklu, Rahmi
    Ting, Richard
    Tewari, Ashutosh
    Akin, Oguz
    Sayman, Haluk B.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (05) : 405 - 416
1234